$16.2 Million is the total value of Antipodean Advisors LLC's 8 reported holdings in Q1 2023. The portfolio turnover from Q4 2022 to Q1 2023 was 50.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| SE | Sell | SEA LTDsponsord ads | $6,058,500 | -66.7% | 70,000 | -80.0% | 37.48% | -38.4% |
| New | INVESTMENT MANAGERS SER TR Iaxs tsla bear dl | $3,190,500 | – | 75,000 | +100.0% | 19.74% | – | |
| ATRA | ATARA BIOTHERAPEUTICS INC | $2,900,000 | -11.6% | 1,000,000 | 0.0% | 17.94% | +63.8% | |
| GDX | Buy | VANECK ETF TRUSTgold miners etf | $2,426,250 | +746.6% | 75,000 | +650.0% | 15.01% | +1468.5% |
| CMAX | CAREMAX INC | $1,134,750 | -26.8% | 425,000 | 0.0% | 7.02% | +35.6% | |
| COIN | New | COINBASE GLOBAL INC | $236,495 | – | 3,500 | +100.0% | 1.46% | – |
| CDLX | Sell | CARDLYTICS INC | $118,825 | -72.6% | 35,000 | -53.3% | 0.74% | -49.2% |
| CVNA | Sell | CARVANA COcl a | $97,900 | -17.4% | 10,000 | -60.0% | 0.61% | +53.0% |
| UPST | Exit | UPSTART HLDGS INC | $0 | – | -10,000 | -100.0% | -0.44% | – |
| GLD | Exit | SPDR GOLD TR | $0 | – | -35,000 | -100.0% | -19.82% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-05-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| CARVANA CO | 21 | Q2 2023 | 38.5% |
| AMAZON COM INC | 20 | Q4 2020 | 33.8% |
| SEA LTD | 19 | Q3 2023 | 60.8% |
| CARDLYTICS INC | 18 | Q3 2023 | 26.3% |
| MEDICINES CO | 18 | Q4 2019 | 19.8% |
| ATARA BIOTHERAPEUTICS INC | 15 | Q3 2023 | 17.9% |
| CONSTELLATION BRANDS INC | 14 | Q4 2016 | 11.1% |
| HERBALIFE NUTRITION LTD | 13 | Q1 2021 | 24.8% |
| CLARIVATE PLC | 11 | Q4 2021 | 24.4% |
| EXACT SCIENCES CORP | 11 | Q2 2019 | 24.6% |
View Antipodean Advisors LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Oncothyreon Inc.Sold out | January 09, 2013 | 0 | 0.0% |
View Antipodean Advisors LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
| 13F-HR | 2021-11-15 |
| 13F-HR | 2021-08-16 |
View Antipodean Advisors LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.